The startup founder says "We're offering Rs.25 lakh base plus 0.1% equity." You nod. You have no idea what 0.1% means in rupees. You don't know when it vests. You don't know how much tax you will pay if you exercise. You have 48 hours to decide.
Most ESOP advice falls into two camps: "Equity is risky, take cash" or "Equity is worth it, you will regret not taking it." Neither helps you evaluate YOUR offer. What you need is a framework - specific numbers, current Indian tax rules, and a 5-minute calculation you can do on your phone.
If you are still negotiating the offer itself, our guides on salary negotiation scripts and timelines and salary negotiation mistakes Indians make have the exact words to use at every stage.
This post was reviewed by a chartered accountant with 14 years of experience in startup taxation and ESOP structuring for Indian companies. Tax rules mentioned are current as of May 2026. Always consult your own CA before making financial decisions.
What ESOPs actually are (the jargon-free version)
An Employee Stock Option Plan (ESOP) is a promise from the company: "If you stay with us for a certain period, you get the right to buy company shares at a fixed price." It is not free shares. It is an option to buy shares later, hopefully at a price lower than what they will be worth.
What Indian startups actually offer:
- ESOPs (Stock Options): The most common. You get the right to buy shares at a predetermined "exercise price" after vesting. You pay to own them.
- ESPS (Employee Stock Purchase Scheme): Less common. You buy shares at a discount to market price, usually through salary deductions.
- SARs (Stock Appreciation Rights): You get the cash equivalent of share price growth without actually buying shares. Rare in Indian startups.
- RSUs (Restricted Stock Units): You get actual shares that vest over time. Common in post-IPO companies and MNCs, rare in early Indian startups.
Vesting: This is the waiting period. The standard Indian startup vesting schedule is 4 years with a 1-year cliff. What this means in practice:
- Year 1: Zero shares vest. If you leave before completing 1 year, you get nothing.
- Year 2: 25% of your total grant vests (the first year's accumulation).
- Year 3: Another 25% vests.
- Year 4: The final 25% vests.
Some companies use monthly or quarterly vesting after the cliff. Always check your grant letter for the exact schedule.
Exercise price: This is what you pay to convert your options into actual shares. If your exercise price is Rs.10 per share and the current fair market value is Rs.100 per share, you pay Rs.10 to buy something worth Rs.100. But you pay tax on the difference (Rs.90) as "perquisite" - more on that in the tax section.
Dilution: Your 0.1% today is not your 0.1% tomorrow. Every time the company raises funding, new shares are created. Your percentage shrinks. A 0.1% stake at Series A might become 0.06% by Series C. This is normal. What matters is whether the company's valuation grows faster than your stake dilutes.
Liquidity events: This is when your paper shares become real money:
- IPO: Shares list on the stock exchange. You can sell them (subject to lock-in periods).
- Acquisition: Another company buys yours. Your shares convert to cash or the acquirer's shares.
- Buyback: The company buys back shares from employees. Rare but happening more often in mature Indian startups.
- Secondary sale: You sell your shares to another investor before an IPO. Usually requires company approval.
The timeline from grant to money: Grant (today) → Vesting starts (1-year cliff) → Options vest over 4 years → You exercise (pay exercise price + tax) → Liquidity event (IPO/acquisition/buyback) → You sell → Money in your account. The gap between grant and money is typically 5-8 years for Indian startups.
The 4 numbers that determine if your ESOPs are worth anything
You do not need a finance degree. You need four numbers. Get them from the company. If they will not share them, that is information too.
Number 1: Current valuation and valuation method
Ask: "What was the post-money valuation in the last funding round?" If the company is pre-Series A, ask for the valuation from the last angel round or the current 409A valuation (the IRS-mandated fair market value for options).
Red flag: They refuse to share the valuation. A company that will not tell you what it is worth is asking you to value its equity blindly.
Number 2: Exercise price vs. current fair market value (FMV)
Ask: "What is the exercise price per share?" and "What is the current FMV per share?" The gap between these two numbers determines your perquisite tax when you exercise.
Example: Exercise price = Rs.50. FMV = Rs.500. Difference = Rs.450 per share. If your grant is for 1,000 shares, your perquisite value is Rs.4.5 lakhs. You will pay tax on this amount in the year you exercise, even if you cannot sell the shares yet.
Number 3: Vesting schedule details
Ask for the exact schedule: cliff period, vesting frequency (monthly/quarterly/annual), and acceleration clauses (what happens in an acquisition). Also ask about the exercise window after leaving - how long do you have to exercise vested options after resignation?
Red flag: An exercise window shorter than 90 days after leaving. This forces you to exercise (and pay tax) before you know if the company will succeed.
Number 4: Total dilution path
Ask: "How many funding rounds do you expect before an IPO or acquisition?" Each round typically dilutes existing shareholders by 15-25%. Two more rounds and your 0.1% becomes roughly 0.06%.
What matters: Not the percentage, but the rupee value. A 0.06% stake in a company worth Rs.1,000 crore is Rs.60 lakhs. A 0.1% stake in a company worth Rs.50 crore is Rs.5 lakhs.
Real example - Rs.25L + 0.1% at a Rs.100 crore startup:
- Company valuation: Rs.100 crore
- Your equity: 0.1% = Rs.10 lakh on paper today
- Vesting: 4 years with 1-year cliff
- Expected dilution: 2 more funding rounds → ~35% total dilution
- Your stake at exit: 0.065%
- If company reaches Rs.500 crore valuation: your stake = Rs.32.5 lakh
- If company fails: your stake = Rs.0
- If company stays at Rs.100 crore: your stake = Rs.6.5 lakh
Indian tax rules for ESOPs (2026)
Indian tax law treats ESOPs as income at two points: when you exercise, and when you sell. Understanding both is critical because the exercise tax hits before you have any cash from the shares.
Tax at exercise (perquisite tax)
When you exercise your options, the difference between the fair market value (FMV) and the exercise price is treated as a "perquisite" - essentially salary income. It is taxed at your marginal income tax rate.
Example:
- Exercise price: Rs.100 per share
- FMV at exercise: Rs.1,000 per share
- Difference: Rs.900 per share
- Number of shares exercised: 500
- Perquisite value: Rs.4.5 lakhs
- Tax at 30% slab: Rs.1.35 lakhs (plus cess)
You pay this tax in the financial year you exercise, even if you cannot sell the shares. You also pay the exercise price (Rs.50,000 in this example) to the company. Total cash outflow: Rs.1.85 lakhs for shares you cannot sell yet.
Tax at sale (capital gains)
When you eventually sell the shares, the difference between the sale price and the FMV at exercise is taxed as capital gains.
- Short-term capital gains (held less than 24 months): Taxed at your marginal income tax rate (up to 30%).
- Long-term capital gains (held more than 24 months): Taxed at 12.5% without indexation benefit (as per the 2024 Budget changes).
The 2020 Budget change - deferred tax for startups
In the 2020 Budget, the Indian government introduced a significant relief for employees of eligible startups (recognized by DPIIT). For these startups, perquisite tax on ESOPs is deferred to the earlier of:
- 5 years from the date of grant, OR
- The date you sell the shares, OR
- The date you leave the company
This means you do not pay perquisite tax at exercise for DPIIT-recognized startups. You pay it later - when you have actual cash from selling shares. Check if your company is DPIIT-recognized. Most well-funded Indian startups are.
Disclaimer: Tax rules change. This section reflects the law as of May 2026. Always consult a chartered accountant before exercising ESOPs or making tax-related decisions. The numbers here are illustrative, not advice.
The decision framework: when to take equity, when to take cash
There is no universal answer. The right mix depends on the company's stage, your financial situation, and your risk tolerance. Here is a framework that accounts for all three.
Scenario A: Seed / Series A, unproven model
Recommended mix: Cash-heavy (90/10).
High failure risk. The company has not proven product-market fit. Most Seed and Series A startups in India fail within 3 years. Your equity is likely worth zero. Maximise guaranteed income and treat any equity as a free lottery ticket.
Scenario B: Series B/C, clear growth path
Recommended mix: Balanced (70/30).
The company has traction - paying customers, recurring revenue, known VCs on the cap table. But there is still no certainty of an exit. Equity has real upside potential, but cash should still dominate. This is the most common scenario for Indian professionals evaluating startup offers.
Scenario C: Pre-IPO / late stage, likely liquidity in 2 years
Recommended mix: Equity-heavy (60/40).
Liquidity is visible - the company has announced IPO plans or is in late-stage acquisition talks. Tax deferral likely applies. The time horizon is short enough that you can reasonably predict whether the equity will convert to cash. This is the only scenario where equity-heavy makes mathematical sense.
The 3 red flags that should make you say no to equity
Red flag 1: The company will not share valuation, exercise price, or FMV. If they hide the numbers, the equity is worth zero by definition.
Red flag 2: The exercise window after leaving is less than 90 days. This forces you to exercise (and pay tax) before you know if the company will succeed. Many good people have been trapped by this clause.
Red flag 3: The company has not raised in 18+ months and is not profitable. A startup that cannot raise funding and cannot self-fund is running out of runway. The equity might never reach a liquidity event.
The "can I afford to lose it all?" test
Before accepting any equity component, ask yourself: "If the company fails and my ESOPs are worth zero, will I regret this decision?"
- If the answer is "I will be fine" - equity is a reasonable bet.
- If the answer is "I will be angry" - reduce the equity component.
- If the answer is "I will be in financial trouble" - do not take equity. Take cash.
Your ESOPs should never be part of your emergency fund calculation. They should not affect your rent, your EMI, or your child's school fees. They are a lottery ticket with better odds than most - but still a lottery ticket.
Real examples from 3 professionals
Person A (Series A, took 20% equity): Joined a Bangalore fintech at Series A. Took Rs.20L base + 0.15% equity. Company raised Series B 18 months later at 4x valuation. His equity is now worth Rs.45 lakh on paper. He has not exercised yet (DPIIT deferral applies). He might never see that money - but the upside is real.
Person B (Series C, took 30% equity): Joined a SaaS company at Series C. Took Rs.28L base + RSUs worth Rs.12L annually. Company went public 2 years later. Her RSUs converted to listed shares. She sold 50% at IPO and held 50%. The equity component returned 3.2x her cash salary over 4 years.
Person C (Seed stage, took 40% equity): Joined an early-stage startup as CTO. Took Rs.15L base + 2% equity. Company shut down after 3 years. His equity was worth zero. He had a family EMI of Rs.45,000. He regretted the decision deeply. The cash he gave up would have covered 3 years of EMI.
The 5-minute evaluation you can do right now
Open a notes app or spreadsheet. This takes 5 minutes and gives you a number to compare against your cash offer.
- Get the 4 numbers. Current valuation, exercise price, FMV, vesting schedule. If you cannot get them, stop here - the equity is worth zero for decision purposes.
- Calculate "if everything goes right" value. Company valuation × your stake percentage × (1 - expected dilution). Example: Rs.100Cr × 0.1% × 0.65 = Rs.6.5 lakh.
- Apply the probability discount. Be honest. Series A startup: 10-15% chance of meaningful exit. Series C: 25-35%. Pre-IPO: 50-60%. Example at 15%: Rs.6.5 lakh × 0.15 = Rs.97,500 expected value.
- Add the tax cost. Perquisite tax at exercise + capital gains at sale. Rough estimate: 25-35% of the gross value. Example: Rs.97,500 × 0.70 = Rs.68,250 after-tax expected value.
- Compare to cash offer. If the cash difference is Rs.3 lakh per year, and your equity's after-tax expected value is Rs.68,250 over 4 years, the cash offer is better. The equity only wins if the company significantly outperforms.
The mental model: ESOPs are a call option on the company's future. They cost you nothing upfront but they cost you in foregone cash. The question is not "will the company succeed?" It is "will the company succeed BY ENOUGH to compensate for the cash I am giving up?" Most do not.
Stuck on the numbers? Talk to someone who's exercised ESOPs before
One Seeker posted her ESOP offer terms on the Amigzo Doubt Board. A Guide who had been through 3 startup exits reviewed it and pointed out a clause she had missed - a 30-day exercise window after leaving that would have forced her to pay Rs.2.8 lakh in tax before knowing if the company would survive. The call was 12 minutes. She renegotiated the clause before signing.
Frequently asked questions
Quick answers about ESOPs and startup compensation in India.
What happens to my ESOPs if I leave before vesting?
Unvested ESOPs are forfeited when you leave - this is standard across all Indian startups. Vested but unexercised ESOPs depend on your exercise window, which is typically 90 days after resignation (though some companies extend this to 1-2 years post the 2020 Budget changes). Always check your grant letter for the specific exercise window. If you do not exercise within that window, the vested ESOPs also lapse.
Can I negotiate for more cash instead of equity?
Yes, and you should always try. Most Indian startups have some flexibility between cash and equity components. Ask: "Would it be possible to shift some of the equity component into base salary?" For Series A and B companies, cash is often easier to negotiate than equity because equity dilutes existing shareholders. For late-stage startups, equity might be more flexible because cash is scarce.
How do I know if the company's valuation is real?
Check three things: (1) Has the company raised from known VC firms (Sequoia, Accel, Matrix, Lightspeed) with published fund sizes? (2) Is the valuation mentioned in credible media (TechCrunch, The Ken, Entrackr)? (3) Does the valuation make sense relative to revenue - early-stage companies at 50x+ revenue multiples are speculative. Ask the recruiter directly: "What was the post-money valuation in the last round?" If they won't tell you, that is a red flag.
What if the company never has a liquidity event?
Then your ESOPs are worth zero. This is the most likely outcome for most Indian startups. According to industry data, over 90% of startups never reach an IPO or acquisition that returns value to employees. That is why you should never count ESOP value in your near-term financial planning. Treat ESOPs as a lottery ticket - nice if it pays off, but not something to base your rent on.
Should I exercise my ESOPs as they vest or wait?
Under current Indian tax law, exercising earlier starts your holding clock for long-term capital gains (which are taxed at lower rates). However, exercising means paying the exercise price plus perquisite tax upfront - cash out of your pocket for an uncertain future return. Most professionals at Indian startups wait until a liquidity event is imminent (IPO announcement, acquisition talks) before exercising, to avoid tying up cash in illiquid equity.